{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:06:04Z","timestamp":1790899564390,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jpeds.2011.04.040","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T21:22:35Z","timestamp":1308950555000},"page":"838-844.e1","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study"],"prefix":"10.1016","volume":"159","author":[{"given":"Nathalie","family":"Guffon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bin-Dorel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Decullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Paillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Guitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fouilhoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2011.04.040_bib1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2011.04.040_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004390050641","article-title":"Incidence of the mucopolysaccharidoses in Northern Ireland","volume":"101","author":"Nelson","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.jpeds.2011.04.040_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","article-title":"The frequency of lysosomal storage diseases in The Netherlands","volume":"105","author":"Poorthuis","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.jpeds.2011.04.040_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/adc.69.3.403","article-title":"Management of mucopolysaccharidosis type III","volume":"69","author":"Cleary","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2011.04.040_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1136\/adc.2004.065482","article-title":"Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study","volume":"90","author":"Fraser","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2011.04.040_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/adc.73.1.77","article-title":"Behaviour in mucopolysaccharide disorders","volume":"73","author":"Bax","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2011.04.040_bib7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1469-8749.1996.tb12114.x","article-title":"Sleep problems in children with Sanfilippo syndrome","volume":"38","author":"Colville","year":"1996","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpeds.2011.04.040_bib8","doi-asserted-by":"crossref","first-page":"e1255","DOI":"10.1542\/peds.2007-0282","article-title":"Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A)","volume":"120","author":"Meyer","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2011.04.040_bib9","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymgme.2007.09.011","article-title":"Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands","volume":"93","author":"Ruijter","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2011.04.040_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jpeds.2011.04.040_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2011.04.040_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","article-title":"Therapy for lysosomal storage disorders","volume":"62","author":"Beck","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jpeds.2011.04.040_bib13","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/00005072-199710000-00010","article-title":"Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics","volume":"56","author":"Jones","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jpeds.2011.04.040_bib14","doi-asserted-by":"crossref","first-page":"10229","DOI":"10.1523\/JNEUROSCI.3558-04.2004","article-title":"Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum","volume":"24","author":"Cressant","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jpeds.2011.04.040_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2011.04.040_bib16","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpeds.2011.04.040_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/00498250601094543","article-title":"The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat","volume":"37","author":"Treiber","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpeds.2011.04.040_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2011.04.040_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ymgme.2009.07.003","article-title":"Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study","volume":"98","author":"Pineda","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2011.04.040_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(07)70194-1","article-title":"Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study","volume":"6","author":"Patterson","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jpeds.2011.04.040_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/GIM.0b013e3181a1b5c5","article-title":"Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment","volume":"11","author":"Shapiro","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2011.04.040_bib22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2009.04.013","article-title":"Pharmacokinetics, safety and tolerability of miglustat in the treatment of pediatric patients with GM2 gangliosidosis","volume":"97","author":"Maegawa","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2011.04.040_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ymgme.2009.12.006","article-title":"Miglustat in adult and juvenile patients with Niemann-Pick disease type C: Long-term data from a clinical trial","volume":"99","author":"Wraith","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2011.04.040_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0883073809344222","article-title":"Long-term miglustat therapy in children with Niemann-Pick disease type C","volume":"25","author":"Patterson","year":"2010","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jpeds.2011.04.040_bib25","first-page":"79","article-title":"L\u2019\u00e9valuation du comportement adaptatif: l\u2019\u00e9chelle de Vineland","volume":"67-68","author":"Fombonne","year":"1995","journal-title":"Handicaps et inadaptations"},{"key":"10.1016\/j.jpeds.2011.04.040_bib26","unstructured":"Sparrow SS, Balla DA, Cicchetti DV. Vineland Adaptive Behavior Scales (Survey Form). American Guidance Service Circle Pines, MN; 1984."},{"key":"10.1016\/j.jpeds.2011.04.040_bib27","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1176\/ajp.126.6.884","article-title":"A teacher rating scale for use in drug studies with children","volume":"126","author":"Conners","year":"1969","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jpeds.2011.04.040_bib28","series-title":"Langage oral et \u00e9crit T2: \u00e9preuves sensorielles et tests de langage, appr\u00e9ciation de l\u2019\u00e9tat du langage","author":"Borel-Maisonny","year":"1997"},{"key":"10.1016\/j.jpeds.2011.04.040_bib29","series-title":"Batterie d\u2019\u00e9valuation cognitive et socio-\u00e9motionnelle: Pratiques psychologiques et recherches cliniques aupr\u00e8s d\u2019enfants atteints de TED","author":"Adrien","year":"2008"},{"key":"10.1016\/j.jpeds.2011.04.040_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(91)90272-E","article-title":"Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique","volume":"197","author":"Davidsson","year":"1991","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpeds.2011.04.040_bib31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jchromb.2008.11.040","article-title":"Rapid quantification of miglustat in human plasma and cerebrospinal fluid by liquid chromatography coupled with tandem mass spectrometry","volume":"877","author":"Guitton","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jpeds.2011.04.040_bib32","series-title":"Nursing pharmacology and therapeutics","author":"O'Bannon","year":"1988"},{"key":"10.1016\/j.jpeds.2011.04.040_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/TCRM.S6865","article-title":"Review of miglustat for clinical management in Gaucher disease type 1","volume":"4","author":"Ficicioglu","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jpeds.2011.04.040_bib34","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/pds.1779","article-title":"Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme","volume":"18","author":"Hollak","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347611004094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347611004094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:22:20Z","timestamp":1712535740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347611004094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0022347611004094"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2011.04.040","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}